The partnership will build off of the AI-powered GI Genius endoscopy module. Through the agreement, Medtronic will pay Cosmo $100 million up front, royalty on net sales and potential milestone payments, according to a Dec. 11 Medtronic news release.
According to Medtronic, the GI Genius module increased adenoma detection rate by 14%. The most recent partnership will also focus on the further development of AI Access, a platform designed to host multiple AI applications.
“The GI Genius module, our first FDA-cleared AI product in gastrointestinal care, represents the initial milestone of this collaboration,” Ken Washington, chief technology officer at Medtronic, said in the news release. “However, the AI Access platform is where our partnership truly crystallizes our vision for healthcare transformation; it’s a springboard for expanding Medtronic’s AI’s potential in healthcare.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
